NLG919
IDO-IN-7 is a potent small molecule inhibitor of indoleamine 2,3-dioxygenase (IDO1), an analogue of NLG-919. It is used in research to investigate the IDO pathway in immunology and oncology, with applications in both in vitro cellular assays and in vivo tumor model studies.
Product Specifications
CAS Number
1402836-58-1
Product Name Alternative
Indoleamine2,3Dioxygenase (IDO), Indoleamine 2,3-Dioxygenase (IDO), Indoleamine2,3Dioxygenase, Indoleamine 2,3-Dioxygenase, Indoleamine 2,3Dioxygenase (IDO), Navoximod, Navoximod analogue, NLG 919, NLG919, NLG-919, NLG919 analogue, NLG-919 analogue, IDO, IDO IN 7, IDOIN7, IDO-IN-7, GDC 0919, GDC0919, GDC-0919, GDC-0919, GDC-0919 analogue
Field of Research
Immunology & Inflammation
Purity
>98%
Bioactivity
IDO pathway inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 10 mg/ml)
Smiles
OC (CC1c2ccccc2-c2cncn12) C1CCCCC1
Molecular Formula
C18H22N2O
Molecular Weight
282.39
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
1-Cyclohexyl-2- (5H-imidazo[5,1-a]isoindol-5-yl) ethanol
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A00223-1-Dylight488 100 µg
Anti-BRG1/SMARCA4 Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details 
GTR15352563 1 Vial
Lentiviral human MRPL38 shRNA (UAS) - Lentiviral human MRPL38 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 